Over two dozen teens who escaped from the Nashville Detention Center still remain at large Tuesday morning. Approximately 32 teens escaped from Woodland Hills juvenile detention facility around 11 p.m. Monday by crawling under a weak spot in a fence that surrounded a yard. The escape happened when a large group of teens at the center went into the yard shortly after officers made shift changes. So far, police have captured 15 of the juveniles and are working with the Department of Children’s Services and the Tennessee Highway Patrol to find the rest of the young fugitives. [USA Today]
In gruesome and bold fashion, a Bronx man decapitated himself in broad daylight Monday morning. The Hunts Point resident parked his 2005 Honda CRV on the street around 9:35 a.m., then reportedly looped a chain around his neck, secured it to a pole, and got back into his car. The unidentified 51-year-old man then stepped on the gas, decapitating himself. [Gawker]
A Colorado woman attempting to send a voice text message on her phone was impaled when her vehicle collided with the guard rail. The guard rail pierced through her upper thigh and buttocks, pinning her in the vehicle until emergency responders were able to use a saw to break her free. Christina Jahnz of Elizabeth, Colorado, was taken to the hospital by paramedics with the pole still stuck in her thigh. Jahnz was immediately taken into surgery, and is now in stable condition. Lesson here (for the billionth time) — DON’T TEXT AND DRIVE! [Jezebel]
The highly anticipated testing of the experimental Ebola virus serum will begin this week at the National Institutes of Health. After an expedited review by the U.S. Food and Drug Administration, researchers were given the green light to begin a human safety trial of the serum. This will be the first test of its type of the Ebola vaccine on humans. The experimental vaccine will first be given to three healthy volunteers to see if they suffer any adverse effects. If deemed safe, it will then be given to another small group of volunteers, aged 18 to 50, to see if it produces a strong immune response to the virus. All volunteers will be monitored closely for side effects. [CNN]
VIDEO SOURCE: News Inc.